Essilorluxottica

CAC 40Health careELFR0000121667

EssilorLuxottica SA is a Franco-Italian vertically integrated multinational holding company registered in Charenton-Le-Pont and headquartered both in Paris and Milan. It designs, produces and markets ophthalmic lenses, equipment and instruments, prescription glasses and sunglasses.

Filings

160 filings

All Inside information70 Voting rights and capital39 Share buyback27 Earnings release12 Universal registration document6 Half-year financial report5 Threshold crossing1

15/10/2025
EssilorLuxottica acquires RetinAI, accelerating transformative AI and data-powered eye health solutions
Inside informationFR
09/10/2025
EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of September 30, 2025
Voting rights and capitalFR
06/10/2025
EssilorLuxottica: Third-Quarter 2025 Revenue Conference Call Invitation
Inside informationFR
25/09/2025
EssilorLuxottica: Essilor Stellest is the first and only FDA market authorized spectacle lens in the United States
Inside informationFR
18/09/2025
EssilorLuxottica: EssilorLuxottica and Meta build on their successful partnership with new AI glasses that offer a glimpse into the future
Inside informationFR
11/09/2025
EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of August 31, 2025
Voting rights and capitalFR
01/09/2025
EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of July 31, 2025
Voting rights and capitalFR
04/08/2025
EssilorLuxottica: EssilorLuxottica acquires Automation & Robotics, advancing high-performance solutions in ophthalmic manufacturing
Inside informationFR
29/07/2025
EssilorLuxottica: Publication of the 2025 Interim Financial Report
Half-year financial reportFR
29/07/2025
Rapport financier semestriel 2025
Half-year financial reportFrench
28/07/2025
EssilorLuxottica: Q2/H1 2025 Results - Sound revenue growth at 7.3% in Q2 and H1, AI glasses speeding up further
Earnings releaseFR
21/07/2025
EssilorLuxottica to acquire PUcore’s division dedicated to the development, manufacturing and sale of ophthalmic lens materials
Inside informationFR
17/07/2025
EssilorLuxottica: Second-Quarter and First-Half 2025 Results Conference Call Invitation
Inside informationFR
09/07/2025
EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of June 30, 2025
Voting rights and capitalFR
20/06/2025
EssilorLuxottica and Meta to launch Oakley Meta, creating a new category of Performance AI glasses for athletes and fans alike
Inside informationFR
17/06/2025
Franchissement de seuils
Threshold crossingFrench
12/06/2025
EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of May 31, 2025
Voting rights and capitalFR
05/06/2025
EssilorLuxottica signs an agreement to acquire A-Look, Seen and OWL retail stores in Malaysia
Inside information
03/06/2025
EssilorLuxottica: successful Euro 1 billion bond issuance
Inside informationFR
03/06/2025
EssilorLuxottica: Result of the payment of dividends in shares and record of the corresponding capital increase
Inside informationFR
30/05/2025
EssilorLuxottica va acquérir les cliniques Optegra, une nouvelle étape clé dans sa stratégie med-tech
Inside informationFrench
20/05/2025
EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of April 30, 2025
Voting rights and capitalFR
06/05/2025
EssilorLuxottica: Disclosure of transactions in own shares
Share buyback
30/04/2025
EssilorLuxottica: EssilorLuxottica 2025 Annual Shareholders’ Meeting
Inside informationFR
29/04/2025
EssilorLuxottica: Déclaration de transactions sur actions propres
Share buybackFrench
22/04/2025
EssilorLuxottica: Disclosure of transactions in own shares
Share buybackFR
15/04/2025
EssilorLuxottica: Disclosure of transactions in own shares
Share buybackFR
11/04/2025
EssilorLuxottica: First-Quarter 2025 Revenue Conference Call Invitation
Inside informationFR
11/04/2025
EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of March 31, 2025
Voting rights and capitalFR
08/04/2025
EssilorLuxottica: Disclosure of transactions in own shares
Share buybackFR
03/04/2025
EssilorLuxottica and Roger Federer Extend Exclusive Global Eyewear Collaboration Between the RF Brand and Oliver Peoples
Inside informationFR
02/04/2025
EssilorLuxottica: EssilorLuxottica’s employee shareholding plans reach record investment, reflecting strong confidence in the Group’s strategy
Inside informationFR
13/03/2025
EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of March 12, 2025
Voting rights and capitalFR
11/03/2025
EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of February 28, 2025
Voting rights and capitalFR
10/03/2025
EssilorLuxottica: 2024 Universal Registration Document filed
Universal registration documentFR
07/03/2025
Dépôt du Document d’enregistrement universel 2024
Universal registration documentFrenchZIP
13/02/2025
EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of January 31, 2025
Voting rights and capitalFR
12/02/2025
EssilorLuxottica: Q4/FY 2024 Results - Sound sales growth and margin expansion in 2024. Smartglasses as a new driver, Nuance off to a promising start
Earnings releaseFR
11/02/2025
EssilorLuxottica acquires the Canadian med-tech start-up Cellview
Inside informationFR
03/02/2025
EssilorLuxottica receives FDA clearance and EU certifications for Nuance Audio, making it available to consumers in the U.S. and Europe
Inside informationFR
21/01/2025
EssilorLuxottica: Déclaration de transactions sur actions propres
Share buybackFrench
15/01/2025
EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of December 31, 2024
Voting rights and capitalFR
14/01/2025
EssilorLuxottica: Déclaration de transactions sur actions propres
Share buybackFrench
07/01/2025
EssilorLuxottica: Déclaration de transactions sur actions propres
Share buybackFrench
02/01/2025
EssilorLuxottica strengthens its presence in the hearing space with the acquisition of an AI-driven tech startup in France
Inside informationFR

About

ISIN: FR0000121667
Ticker: EL
LEI: 549300M3VH1A3ER1TB49
Sector: Health care
Founded: 1971
Employees: 150,000
Country of registration: FR
Last filing: 29/07/2026, 18:00

Wikipedia

Description from Wikidata, CC0 licence.

Filing history

Filings per month

Sept 23May 24Jan 25Sept 25Aug 26

Document types

Across the whole archive